Skip to content

Ganglioside GM1 (Serum)

Published: August 9, 2026Updated: August 16, 2026

This test measures the level of GM1 ganglioside, a complex sugar-lipid found in the body’s cells, particularly in the brain and nervous system. It may be used to help diagnose or monitor certain inherited or acquired conditions affecting these structures.

Quick summary

["GM1 ganglioside levels can help identify or track conditions impacting nerve cells."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
57969-8
Short code
GD1a Gangl IgM Ser Ql
Synonyms
GD1a Gangl IgM Ser Ql
Category
chemistry
Sample
serum
Container
Red-top tube (SST)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
CPT
82784
Specimen volume
5 mL
Stability
Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
Hemolysis max
500
Lipemia max
1000
Icterus max
500
TAT
4–24 hours
Order
routine

Why This Test Might Be Ordered

Your healthcare provider may recommend this test if you have symptoms or a history suggestive of a condition like **Gaucher disease**, **Niemann-Pick disease**, or other lysosomal storage disorders. It may also be part of a broader evaluation for neurological issues or inherited metabolic disorders.

What to Expect Before the Test

No special preparation is typically needed. You may have a blood sample drawn from a vein in your arm, similar to other blood tests. If you’re on blood thinners or have a history of bleeding disorders, let your provider know.

What the Results Mean

Results can vary widely depending on the condition being tested. Elevated levels may suggest certain inherited disorders, while normal or low levels may help rule out specific conditions. Your provider will interpret results in the context of your medical history and symptoms.

Common Conditions Monitored

This test is often linked to diagnosing or monitoring lysosomal storage disorders, such as **Gaucher disease** or **Niemann-Pick disease**, which affect how your body breaks down certain fats. It may also be used in research or specialized clinical settings for rare genetic conditions.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

◆Associated findings1

Short name

GM1 Ganglioside

Frequently asked questions

What does an abnormal GM1 level indicate?
An abnormal result—either elevated or low—may suggest a lysosomal storage disorder or another condition affecting GM1 metabolism. Your provider will discuss these findings with you and may recommend further testing or follow-up.
How is this test different from other blood tests?
Unlike more common blood tests (e.g., cholesterol or glucose), GM1 ganglioside testing is specialized and often reserved for diagnosing rare genetic or metabolic disorders. It’s not a routine screening test for most people.
Can diet or lifestyle affect GM1 levels?
There’s no strong evidence that diet or lifestyle changes significantly impact GM1 levels in most cases. However, if you have a known condition being monitored, your provider may recommend specific dietary guidance based on your diagnosis.
  1. 1
    MedlinePlus — Laboratory TestsSource
  2. 2
    Lab Tests OnlineSource
  3. 3
    Mayo Clinic — Tests & ProceduresSource

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy